Your Article Summary
See Latest ArticlesPremature ejaculation
Der Urologe, 07/02/09
Porst H - With prevalence rates of 20%–25% premature ejaculation (PE) represents the most frequent sexual dysfunction in men. Among the medications considered for PE, oral therapy with selective serotonin re-uptake inhibitors (SSRI), Dapoxetine (the first officially approved medication for PE) and topical therapy with lidocaine/prilocaine-containing medications are given priority.
Related Articles
Treatment of Premature Ejaculation in the Asia-Pacific Region: Results from a Phase III Double-blind, Parallel-group Study of Dapoxetine
The Journal of Sexual Medicine, 11/06/09
Relevance Score: 66%
Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure
Gynecological Endocrinology, 11/16/09
Relevance Score: 46%
Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species
Oncogene, 10/29/09
Relevance Score: 43%
Premature hair greying may predict reduced bone mineral density in Graves' disease
Irish Journal of Medical Science, 10/27/09
Relevance Score: 42%
In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause
Journal of Assisted Reproduction and Genetics, 10/26/09
Relevance Score: 42%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09
Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer
Cancer Science, 12/04/09